Target intelligence / Profile preview

Superkiller complex protein 3 (SKI3)

Target
SKI3
Molecular classification
Other (RNA metabolism protein), Structural component of the SKI complex, Tetratricopeptide repeat domain protein
01

Overview

Superkiller complex protein 3 (SKI3) is a core structural subunit of the cytoplasmic SKI complex, which partners with the RNA exosome to facilitate the 3'-to-5' degradation of cytoplasmic mRNAs as part of mRNA surveillance and decay pathways[1][2][3][4][5]. SKI3 is a large tetratricopeptide repeat (TPR) protein, acting as a scaffold within the SKI complex that assembles with the RNA helicase SKI2 and the WD repeat protein SKI8 in a conserved 1:1:2 stoichiometry[1][2][3][5]. While SKI2 provides RNA helicase activity, SKI3 and SKI8 are considered non-enzymatic structural components that coordinate complex assembly and modulation[1][2][3]. The SKI complex is conserved from yeast (where it was historically associated with viral resistance) to humans, where the SKI3 homolog is encoded by the TTC37 gene[1][2][3]. In humans, biallelic mutations in TTC37/SKI3 cause tricho-hepatic-enteric syndrome, a rare multisystem disorder. In general, SKI3 is not considered a direct therapeutic target (such as a receptor, enzyme, or transporter), nor are there currently drugs known to act on SKI3 or the SKI complex in clinical use.

Other names
SKIC3KIAA0372TTC37ThespinTHESTPR repeat protein 37Tetratricopeptide repeat protein 37Tricho-hepatic-enteric syndrome proteinSki3p (yeast)Superkiller complex protein 3 homologSki complex component SKI3
02

Biological functions

RNA decay (specifically, 3'-to-5' cytoplasmic mRNA degradation)mRNA surveillance and quality controlExosome cofactor activityRegulation of mRNA abundance
03

Disease associations

Other (mutations in human TTC37, the SKI3 homolog, cause tricho-hepatic-enteric syndrome)

Beyond the preview

Go deeper on Superkiller complex protein 3 (SKI3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Superkiller complex protein 3 (SKI3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call